These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Orthotopic liver transplantation for metastases of bronchial carcinoid tumor]. Le Hello C; Auvray S; Letellier P; Segol P Gastroenterol Clin Biol; 1992; 16(3):281-3. PubMed ID: 1349869 [TBL] [Abstract][Full Text] [Related]
28. Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Fossmark R; Sørdal Ø; Jianu CS; Qvigstad G; Nordrum IS; Boyce M; Waldum HL Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1067-75. PubMed ID: 23072686 [TBL] [Abstract][Full Text] [Related]
29. Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy. Ardill JE; Johnston BT; McCance DR; Eatock M Ann Clin Biochem; 2017 Mar; 54(2):297-301. PubMed ID: 27638929 [TBL] [Abstract][Full Text] [Related]
30. Chromogranin A as a determinant of midgut carcinoid tumour volume. Kölby L; Bernhardt P; Swärd C; Johanson V; Ahlman H; Forssell-Aronsson E; Stridsberg M; Wängberg B; Nilsson O Regul Pept; 2004 Aug; 120(1-3):269-73. PubMed ID: 15177946 [TBL] [Abstract][Full Text] [Related]
32. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids. Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821 [TBL] [Abstract][Full Text] [Related]
33. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver. Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320 [TBL] [Abstract][Full Text] [Related]
34. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286 [TBL] [Abstract][Full Text] [Related]
35. The clinical use of somatostatin analogues in the treatment of cancer. Lamberts SW; Krenning EP; Klijn JG; Reubi JC Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):29-49. PubMed ID: 1975166 [TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal carcinoid tumours. Histogenetic, histochemical, immunohistochemical, clinical and therapeutic aspects. Wilander E; Lundqvist M; Oberg K Prog Histochem Cytochem; 1989; 19(2):1-88. PubMed ID: 2662260 [TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management. Modlin IM; Moss SF; Oberg K; Padbury R; Hicks RJ; Gustafsson BI; Wright NA; Kidd M Med J Aust; 2010 Jul; 193(1):46-52. PubMed ID: 20618115 [TBL] [Abstract][Full Text] [Related]
38. Measurements of chromogranin B can serve as a complement to chromogranin A. Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339 [TBL] [Abstract][Full Text] [Related]